1-6 of 6
Jacqueline Lehmann-Che
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Oncogenic TRIM37 Links Chemoresistance and Metastatic Fate in Triple-Negative Breast Cancer

Available to Purchase
Piotr Przanowski, Song Lou, Rachisan Djiake Tihagam, Tanmoy Mondal, Caroline Conlan, Gururaj Shivange, Ilyas Saltani, Chandrajeet Singh, Kun Xing, Benjamin B. Morris, Marty W. Mayo, Luis Teixeira, Jacqueline Lehmann-Che, Jogender Tushir-Singh, Sanchita Bhatnagar
Journal: Cancer Research
Cancer Res (2020) 80 (21): 4791–4804.
https://doi.org/10.1158/0008-5472.CAN-20-1459
Published: 03 November 2020
View article titled, Oncogenic TRIM37 Links Chemoresistance and Metastatic Fate in Triple-Negative Breast Cancer
Open the PDF for Oncogenic TRIM37 Links Chemoresistance and Metastatic Fate in Triple-Negative Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract P3-08-25: Simosein registry, the French national real-life prospective evaluation of the impact of Endopredict® (EPclin) on treatment decision in ER-positive, HER2-negative breast cancers

Free
Jacqueline Lehmann-Che, Jennifer Wong, Lucie Tixier, Ludovic Lacroix, Magali Triki-Lacroix, Pierre-Jean Lamy, Agnes Garnier, Véronique Quillien, Florence Godey, Isabelle Soubeyran, Gaëtan MacGrogan, Laurent Arnould, Juliette Haudebourg, Anne Tallet, Linda Dainese, Caroline Hugonin, Frédérique Penault-Llorca
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): P3-08-25.
https://doi.org/10.1158/1538-7445.SABCS19-P3-08-25
Published: 15 February 2020
View article titled, Abstract P3-08-25: Simosein registry, the French national real-life prospective evaluation of the impact of Endopredict® (EPclin) on treatment decision in ER-positive, HER2-negative breast cancers
Journal Articles

Recommended Guidelines for Validation, Quality Control, and Reporting of TP53 Variants in Clinical Practice

Free
Bernard Leroy, Mandy L. Ballinger, Fanny Baran-Marszak, Gareth L. Bond, Antony Braithwaite, Nicole Concin, Lawrence A. Donehower, Wafik S. El-Deiry, Pierre Fenaux, Gianluca Gaidano, Anita Langerød, Eva Hellstrom-Lindberg, Richard Iggo, Jacqueline Lehmann-Che, Phuong L. Mai, David Malkin, Ute M. Moll, Jeffrey N. Myers, Kim E. Nichols, Sarka Pospisilova, Patricia Ashton-Prolla, Davide Rossi, Sharon A. Savage, Louise C. Strong, Patricia N. Tonin, Robert Zeillinger, Thorsten Zenz, Joseph F. Fraumeni, Jr, Peter E.M. Taschner, Pierre Hainaut, Thierry Soussi
Journal: Cancer Research
Series: Author Choice
Cancer Res (2017) 77 (6): 1250–1260.
https://doi.org/10.1158/0008-5472.CAN-16-2179
Published: 14 March 2017
View article titled, Recommended Guidelines for Validation, Quality Control, and Reporting of TP53 Variants in Clinical Practice
Open the PDF for Recommended Guidelines for Validation, Quality Control, and Reporting of TP53 Variants in Clinical Practice in another window
Includes: Supplementary data
Journal Articles

Integrin α5β1 Plays a Critical Role in Resistance to Temozolomide by Interfering with the p53 Pathway in High-Grade Glioma

Free
Hana Janouskova, Anne Maglott, David Y. Leger, Catherine Bossert, Fanny Noulet, Eric Guerin, Dominique Guenot, Sophie Pinel, Pascal Chastagner, François Plenat, Natacha Entz-Werle, Jacqueline Lehmann-Che, Julien Godet, Sophie Martin, Jan Teisinger, Monique Dontenwill
Journal: Cancer Research
Cancer Res (2012) 72 (14): 3463–3470.
https://doi.org/10.1158/0008-5472.CAN-11-4199
Published: 15 July 2012
View article titled, Integrin α5β1 Plays a Critical Role in Resistance to Temozolomide by Interfering with the p53 Pathway in High-Grade Glioma
Open the PDF for Integrin α5β1 Plays a Critical Role in Resistance to Temozolomide by Interfering with the p53 Pathway in High-Grade Glioma in another window
Includes: Supplementary data
Journal Articles

High Frequency of TP53 Mutation in BRCA1 and Sporadic Basal-like Carcinomas but not in BRCA1 Luminal Breast Tumors

Free
Elodie Manié, Anne Vincent-Salomon, Jacqueline Lehmann-Che, Gaelle Pierron, Elisabeth Turpin, Mathilde Warcoin, Nadège Gruel, Ingrid Lebigot, Xavier Sastre-Garau, Rosette Lidereau, Audrey Remenieras, Jean Feunteun, Olivier Delattre, Hugues de Thé, Dominique Stoppa-Lyonnet, Marc-Henri Stern
Journal: Cancer Research
Cancer Res (2009) 69 (2): 663–671.
https://doi.org/10.1158/0008-5472.CAN-08-1560
Published: 15 January 2009
View article titled, High Frequency of TP53 Mutation in BRCA1 and Sporadic Basal-like Carcinomas but not in BRCA1 Luminal Breast Tumors
Open the PDF for High Frequency of TP53 Mutation in BRCA1 and Sporadic Basal-like Carcinomas but not in BRCA1 Luminal Breast Tumors in another window
Includes: Supplementary data
Journal Articles

DNA arrays predictive markers of chemosensitivity to epirubicin-cyclophosphamide (EC) then docetaxel (ECD) primary chemotherapy for localized breast cancer

Free
Sabrina Carpentier, Fabien Valet, Charles Decraene, Frederique Spyratos, Patricia de Cremoux, Jean Philippe Meyniel, Veronique Scott, Jacqueline Lehmann-Che, Brigitte Sigal, Marie-Christine Mathieu, Philippe Bertheau, Jean Marc Guinebretriere, Jean Yves Pierga, Suzette Delaloge, Etienne Brain, Michel Marty, Sergio Roman-Roman, Bernard Asselain, Emmanuel Barillot
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 3620.
Published: 01 May 2008
View article titled, DNA arrays predictive markers of chemosensitivity to epirubicin-cyclophosphamide (EC) then docetaxel (ECD) primary chemotherapy for localized breast cancer